Bayer signs MoU with Russia; AZ to cut 400 jobs in U.S.;

> Bayer ($BAY) has signed a memorandum of understanding with Russia concerning pharmaceutical production. Article

> AstraZeneca ($AZN) said last week it will cut 400 jobs from its U.S. commercial business to streamline operations. Story

> Pharma Discrete Dosage Slider intelligent Wireless (DDSi WL) is electronic packaging that uses cardboard coated with conductive ink and an RFID chip to transmit data on pill consumption to healthcare providers and caregivers. The packaging can communicate with a mobile phone to display data, keep a diary or send SMS reminders. Item

> Vicinity Manufacturing has released an upgrade to its batch manufacturing software for Microsoft ($MSFT) Dynamics. Release

> Generics-maker Teva ($TEVA) was given a conditional go-ahead by regulators last week for its $6.8 billion acquisition of Cephalon ($CEPH). Story

> Niche generics maker Akorn will acquire GMP manufacturing facilities for injectables from Indian contract manufacturer Kilitch Drugs, as well as assets of NBZ Pharma, for $52 million in cash and future contingent payments. Article

> Uganda-based Quality Chemical Industries expects to be manufacturing by end of year the once-per-day antiretroviral drug Tenofovir. Story

> Contract manufacturer Anteco Pharma is breaking ground on a $3.5 million, 25,000-square-foot addition in Lodi, WI. Item

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.